USFDA gives approval to Wockhardt for its ANDA (Abbreviated New Drug Application) for 0.1% ophthalmic solution of Olopatadine HCL, manufactured in Montreal, Canada, it is an eye drop and is a generic version of Patanol marketed in the US by Alcon, a subsidiary of Novartis.
Wockhardt Ltd is a biotechnology and pharmaceutical company, which is included manufacturing and marketing of biopharmaceuticalformulations and pharmaceutical, active pharmaceutical ingredient (APIs) and vaccines.
The company’s scrip opened at Rs 614.9 which had a Rs 615.3 and 610.05 of high and low, 63871 NSE+BSE share were traded on the counter and Rs 6689.63cr is a current market cap.
For Quick Trial – 8962000225 ✔
or mail us here: email@example.com